Microcracks: an alternative index for evaluating bone biomechanical quality.

Area of Science:

• Bone Biology
• Skeletal Physiology
• Estrogen Replacement Therapy

Background:

• Ovariectomy (OVX) in rats leads to bone quality degradation.
• Estrogen deficiency significantly impacts bone biomechanics.
• Microcracks are potential indicators of bone health.

Purpose of the Study:

• To investigate microcracks as a biomarker for bone biomechanical quality changes in OVX rats.
• To assess the efficacy of 17 Beta-estradiol (EST) in mitigating OVX-induced bone alterations.
• To correlate microcrack parameters with bone mineral density and mechanical properties.

Main Methods:

• 98 Sprague-Dawley rats underwent OVX or sham surgery, with some receiving EST.
• Bone Mineral Density (BMD) measured by DXA; bone histomorphometry performed.
• Vertebral compressive testing and in vitro fatigue loading to assess microcracks (CrDn, CrSDn).

Main Results:

• OVX rats showed increased microcrack density (CrDn) and surface density (CrSDn) compared to sham and EST groups.
• Estrogen therapy (EST) reduced microcrack parameters and improved bone quality markers.
• Microcrack parameters correlated with decreased bone mineral density and mechanical properties in OVX rats.

Conclusions:

• Microcrack parameters effectively reflect bone biomechanical quality changes induced by OVX in rats.
• Microcracks serve as a sensitive index for evaluating the impact of estrogen deficiency and replacement therapy.
• These findings highlight the utility of microcracks in assessing bone health and therapeutic interventions.